InspireMD Q1 2024 GAAP EPS $(0.21) Misses $(0.15) Estimate, Sales $1.511B Beat $1.384M Estimate
InspireMD Q1 2024 GAAP EPS $(0.21) Misses $(0.15) Estimate, Sales $1.511B Beat $1.384M Estimate
InspireMD 2024年第一季度公认会计准则每股收益美元（0.21）未达到预期（0.15）美元，销售额为15.11亿美元，超过13.84万美元的预期
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.15) by 40 percent. This is a 60.38 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $1.511 billion which beat the analyst consensus estimate of $1.384 million by 109.08K percent. This is a 121.85K percent increase over sales of $1.239 million the same period last year.
InspireMD（纳斯达克股票代码：NSPR）公布的季度亏损为每股0.21美元，比分析师普遍预期的0.15美元（0.15美元）低40％。这比去年同期每股亏损0.53美元（0.53）增长了60.38％。该公司公布的季度销售额为15.11亿美元，比分析师普遍预期的13.84亿美元高出10.98万个百分点。这比去年同期的123.9万美元销售额增长了12.185万个百分点。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。